+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 8a65 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Small molecule stabilizer (compound 3) for FOXO1 and 14-3-3 | ||||||
要素 |
| ||||||
キーワード | STRUCTURAL PROTEIN / 14-3-3 / FOXO1 / Stabilization | ||||||
機能・相同性 | 機能・相同性情報 cellular response to hyperoxia / regulation of transcription initiation by RNA polymerase II / AKT-mediated inactivation of FOXO1A / FOXO-mediated transcription of cell cycle genes / AKT phosphorylates targets in the nucleus / positive regulation of smooth muscle cell apoptotic process / regulation of neural precursor cell proliferation / neuronal stem cell population maintenance / response to fatty acid / negative regulation of stress-activated MAPK cascade ...cellular response to hyperoxia / regulation of transcription initiation by RNA polymerase II / AKT-mediated inactivation of FOXO1A / FOXO-mediated transcription of cell cycle genes / AKT phosphorylates targets in the nucleus / positive regulation of smooth muscle cell apoptotic process / regulation of neural precursor cell proliferation / neuronal stem cell population maintenance / response to fatty acid / negative regulation of stress-activated MAPK cascade / Regulation of FOXO transcriptional activity by acetylation / negative regulation of cardiac muscle hypertrophy in response to stress / regulation of reactive oxygen species metabolic process / cellular response to cold / FOXO-mediated transcription of cell death genes / temperature homeostasis / protein acetylation / regulation of epidermal cell division / protein kinase C inhibitor activity / negative regulation of fat cell differentiation / positive regulation of epidermal cell differentiation / keratinocyte development / blood vessel development / keratinization / fat cell differentiation / intracellular glucose homeostasis / regulation of cell-cell adhesion / Constitutive Signaling by AKT1 E17K in Cancer / Regulation of gene expression in beta cells / Regulation of localization of FOXO transcription factors / keratinocyte proliferation / phosphoserine residue binding / negative regulation of keratinocyte proliferation / Activation of BAD and translocation to mitochondria / cellular response to nitric oxide / establishment of skin barrier / negative regulation of protein localization to plasma membrane / canonical Wnt signaling pathway / negative regulation of insulin secretion / FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / positive regulation of autophagy / negative regulation of stem cell proliferation / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / positive regulation of protein localization / RHO GTPases activate PKNs / energy homeostasis / positive regulation of gluconeogenesis / negative regulation of innate immune response / protein sequestering activity / protein kinase A signaling / protein export from nucleus / cellular response to starvation / positive regulation of cell adhesion / release of cytochrome c from mitochondria / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / positive regulation of protein export from nucleus / stem cell proliferation / protein phosphatase 2A binding / Translocation of SLC2A4 (GLUT4) to the plasma membrane / promoter-specific chromatin binding / TP53 Regulates Metabolic Genes / negative regulation of protein kinase activity / MAPK6/MAPK4 signaling / negative regulation of canonical Wnt signaling pathway / chromatin DNA binding / DNA-binding transcription repressor activity, RNA polymerase II-specific / beta-catenin binding / cellular response to insulin stimulus / autophagy / intrinsic apoptotic signaling pathway in response to DNA damage / positive regulation of protein catabolic process / protein localization / insulin receptor signaling pathway / regulation of protein localization / cellular response to oxidative stress / gene expression / positive regulation of cell growth / DNA-binding transcription activator activity, RNA polymerase II-specific / Interleukin-4 and Interleukin-13 signaling / sequence-specific DNA binding / nucleic acid binding / regulation of cell cycle / DNA-binding transcription factor activity, RNA polymerase II-specific / cadherin binding / positive regulation of apoptotic process / DNA-binding transcription factor activity / RNA polymerase II cis-regulatory region sequence-specific DNA binding / negative regulation of DNA-templated transcription / DNA damage response / chromatin binding / ubiquitin protein ligase binding / chromatin / negative regulation of apoptotic process / regulation of transcription by RNA polymerase II / apoptotic process / protein kinase binding / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 1.6 Å | ||||||
データ登録者 | Kenanova, D.N. / Visser, E.J. / Virta, J. / Sijbesma, E. / Centorrino, F. / Zhong, M. / Vickery, H. / Neitz, J. / Brunsveld, L. / Ottmann, C. / Arkin, M.R. | ||||||
資金援助 | オランダ, 1件
| ||||||
引用 | ジャーナル: Acs Cent.Sci. / 年: 2023 タイトル: A Systematic Approach to the Discovery of Protein-Protein Interaction Stabilizers. 著者: Kenanova, D.N. / Visser, E.J. / Virta, J.M. / Sijbesma, E. / Centorrino, F. / Vickery, H.R. / Zhong, M. / Neitz, R.J. / Brunsveld, L. / Ottmann, C. / Arkin, M.R. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 8a65.cif.gz | 72.8 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb8a65.ent.gz | 50.9 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 8a65.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 8a65_validation.pdf.gz | 789.6 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 8a65_full_validation.pdf.gz | 793.2 KB | 表示 | |
XML形式データ | 8a65_validation.xml.gz | 15.2 KB | 表示 | |
CIF形式データ | 8a65_validation.cif.gz | 22.8 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/a6/8a65 ftp://data.pdbj.org/pub/pdb/validation_reports/a6/8a65 | HTTPS FTP |
-関連構造データ
関連構造データ | 8a62C 8a68C 8a6fC 8a6hC 8admC 8afnC 8av0C 4jc3S S: 精密化の開始モデル C: 同じ文献を引用 (文献) |
---|---|
類似構造データ | 類似検索 - 機能・相同性F&H 検索 |
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 26542.914 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: SFN, HME1 / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P31947 | ||||||
---|---|---|---|---|---|---|---|
#2: タンパク質・ペプチド | 分子量: 1136.090 Da / 分子数: 1 / 由来タイプ: 合成 / 由来: (合成) Homo sapiens (ヒト) / 参照: UniProt: Q12778 | ||||||
#3: 化合物 | #4: 化合物 | ChemComp-L70 / ( | #5: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | Y | |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.6 Å3/Da / 溶媒含有率: 52.64 % |
---|---|
結晶化 | 温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 詳細: 0.095 M HEPES pH 7.3, 0.19 M CaCl2, 5% glycerol, 25% PEG 400 |
-データ収集
回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
---|---|
放射光源 | 由来: シンクロトロン / サイト: PETRA III, DESY / ビームライン: P11 / 波長: 1.03322 Å |
検出器 | タイプ: DECTRIS EIGER X 16M / 検出器: PIXEL / 日付: 2021年11月11日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.03322 Å / 相対比: 1 |
反射 | 解像度: 1.6→45.47 Å / Num. obs: 518652 / % possible obs: 100 % / 冗長度: 13.5 % / CC1/2: 1 / Net I/σ(I): 55.7 |
反射 シェル | 解像度: 1.6→1.63 Å / Num. unique obs: 1881 / CC1/2: 0.997 |
-解析
ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: 4JC3 解像度: 1.6→45.47 Å / Cor.coef. Fo:Fc: 0.961 / Cor.coef. Fo:Fc free: 0.948 / SU B: 1.142 / SU ML: 0.042 / 交差検証法: THROUGHOUT / ESU R: 0.078 / ESU R Free: 0.078 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : REFINED INDIVIDUALLY
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.9 Å / 減衰半径: 0.9 Å / VDWプローブ半径: 1.1 Å / 溶媒モデル: MASK | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 18.161 Å2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.6→45.47 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 1.6→1.642 Å / Total num. of bins used: 20
|